Bay Area's Tricia Closes $57.5M Series D, Pushes Into Phase III Trial
Proceeds will be used to complete the ongoing pivotal TRCA-301 Phase 3 clinical trial of TRC101. Source: BioSpace
Proceeds will be used to complete the ongoing pivotal TRCA-301 Phase 3 clinical trial of TRC101. Source: BioSpace
Kerrisdale believes that Prothena's lead drug NEOD001 will fail in its current Phase 2b and Phase 3 trials. Source: BioSpace
Exonics Therapeutics closed on a $40M Series A financing which was led by The Column Group. Source: BioSpace
With worldwide spending on prescription drugs increasing from an estimated $774B in 2017 to over $1 trillion in 2022, a rising tide of pharmaceutical sales is lifting a lot of…
Salaries and total compensation can range from $300,000 to $500,000 per year for these employees – whether they have a Ph.D. or are just out of college. Source: BioSpace
Approval is based on Phase III results that showed Alecensa extended the average time that people lived without their disease worsening compared to crizotinib. Source: BioSpace
Harris fired the first shots on Monday. Source: BioSpace
Takeda inked a collaboration deal to develop and commercialize Portal's needle-free drug delivery device for use with some of Takeda's biologic medicines. Source: BioSpace
Bristol-Myers is initiating a Phase III clinical trial of BMS-986205 with nivolumab in patients with advanced melanoma. Source: BioSpace
The increased funding showcases investor confidence in Counsyl’s leading genetic screening products and business model. Source: BioSpace